Intravascular ultrasound assessment of coronary artery involvement in Fabry disease

Aim We used intravascular ultrasound (IVUS) to characterize coronary artery involvement in patients with Fabry disease (FD). Methods Nine FD patients (5 women) were matched to 10 control patients (5 women) chosen from our IVUS database. Standard volumetric IVUS analyses were performed along with ass...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of inherited metabolic disease 2008-12, Vol.31 (6), p.753-760
Hauptverfasser: Kovarnik, T, Mintz, G. S, Karetova, D, Horak, J, Bultas, J, Skulec, R, Skalicka, H, Aschermann, M, Elleder, M, Linhart, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim We used intravascular ultrasound (IVUS) to characterize coronary artery involvement in patients with Fabry disease (FD). Methods Nine FD patients (5 women) were matched to 10 control patients (5 women) chosen from our IVUS database. Standard volumetric IVUS analyses were performed along with assessment of plaque echodensity. Results Plaques in FD patients were diffuse and hypoechogenic compared with more focal and more echogenic lesions in control patients. Echogenicity of plaques was significantly lower in FD patients (median 30.7 ± 12.9 vs 55.9 ± 15.7, p = 0.0052, mean 37.2 ± 15.6 vs 66.2 ± 13.3, p = 0.0014). Diffusiveness was assessed as differences between mean and median plaque burden versus the plaque burden in each of the analysed cross-sections. These differences were lower in FD vs controls (5.8 ± 4.8 vs 8.7 ± 6.6, p < 0.001 for mean, and 5.8 ± 4.9 vs 8.8 ± 7.3, p < 0.001 for median) indicating a more diffuse involvement. The occurrence of lipid cores was significantly higher in FD patients than in controls (2.4 ± 1.5 vs 1.0 ± 0.94, p = 0.02). Conclusion IVUS showed diffuse hypoechogenic plaques in patients with FD. The explanation may be higher lipid content in plaques and accumulation of glycosphingolipid in smooth-muscle and endothelial cells.
ISSN:0141-8955
1573-2665
DOI:10.1007/s10545-008-0794-0